IDH1 and central nervous system cancer: LGG, a diffuse low- and intermediate-grade glioma (WHO grades II and III), is a rare glioma that can be divided into different subtypes based on IDH1/2 mutation status and the presence of 1p19q co-deletion (Brat et al., 2015).